Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEW YORK, May 29, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA) today announced the Government's acceptance of SIGA's second delivery of its proprietary smallpox antiviral drug, Arestvyr™, to the United States Government's Strategic National Stockpile (SNS) under SIGA's contract with the Biomedical Advanced Research and Development Authority (BARDA).
Help employers find you! Check out all the jobs and post your resume.
NEW YORK, May 29, 2013 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (Nasdaq:SIGA) today announced the Government's acceptance of SIGA's second delivery of its proprietary smallpox antiviral drug, Arestvyr™, to the United States Government's Strategic National Stockpile (SNS) under SIGA's contract with the Biomedical Advanced Research and Development Authority (BARDA).
Help employers find you! Check out all the jobs and post your resume.
